| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $901.5M | -69.7% |
| Cost of Revenue | $1.78B | -21.7% |
| Gross Profit | -$877.2M | -224.6% |
| R&D Expense | $277.2M | -13.8% |
| SG&A Expense | $147.5M | +0.6% |
| Operating Income | -$1.71B | -4348.9% |
| Interest Expense | $1.2M | -8.9% |
| Pre-tax Income | -$1.71B | -2206.5% |
| Income Tax | $96.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $274.6M | -18.9% |
| Short-term Investments | $311.3M | -40.3% |
| Accounts Receivable | $160.4M | -74.2% |
| Inventory | $645.9M | -55.3% |
| Current Assets | $2.03B | -38.4% |
| Total Assets | $2.63B | -42.7% |
| Current Liabilities | $1.04B | +16.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$313.3M | -74.0% |
| Capital Expenditures | $108.2M | -36.6% |
| Investing Cash Flow | $416.3M | +254.8% |
| Financing Cash Flow | -$20.1M | -68.4% |
| Free Cash Flow | -$421.5M | -20.2% |
| +107.1% |
| Net Income | -$1.25B | -3754.5% |
| EPS (Basic) | -$31.64 | -5286.9% |
| EPS (Diluted) | -$31.64 | -5373.3% |
| Stockholders' Equity |
| $658.3M |
| -72.7% |